tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

INSM Stock Latest News

Insmed’s Earnings Call Highlights Record Growth and Strategic Moves
Company AnnouncementsInsmed’s Earnings Call Highlights Record Growth and Strategic Moves
56s ago
INSM
Insmed price target raised to $108 from $105 at Truist
PremiumThe Fly
Insmed price target raised to $108 from $105 at Truist
11h ago
INSM
Insmed price target lowered to $96 from $97 at Stifel
PremiumThe Fly
Insmed price target lowered to $96 from $97 at Stifel
12h ago
INSM
Insmed’s Strategic Growth Potential and Market Opportunities Justify Buy Rating
PremiumRatings
Insmed’s Strategic Growth Potential and Market Opportunities Justify Buy Rating
12h ago
INSM
Insmed’s Strong 2024 Growth and Promising Pipeline
PremiumCompany Announcements
Insmed’s Strong 2024 Growth and Promising Pipeline
21h ago
INSM
Ritu Baral’s Buy Rating for Insmed Supported by Strong Financials and Promising Pipeline
PremiumRatingsRitu Baral’s Buy Rating for Insmed Supported by Strong Financials and Promising Pipeline
1d ago
INSM
Insmed Board Member Alfred Altomari to Step Down
Premium
Company Announcements
Insmed Board Member Alfred Altomari to Step Down
2d ago
8K
INSM
Insmed reports Q4 EPS ($1.32), consensus ($1.16)
Premium
The Fly
Insmed reports Q4 EPS ($1.32), consensus ($1.16)
2d ago
INSM
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech analyst holds an analyst/industry conference call
2d ago
INSM
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
3d ago
ANTX
INSM
INSM Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
INSM Upcoming Earnings Report: What to Expect?
4d ago
INSM
Insmed price target raised to $97 from $88 at Stifel
PremiumThe Fly
Insmed price target raised to $97 from $88 at Stifel
10d ago
INSM
Insmed price target raised to $92 from $83 at JPMorgan
PremiumThe FlyInsmed price target raised to $92 from $83 at JPMorgan
15d ago
INSM
Insmed’s Brensocatib NDA Accepted by FDA
Premium
Company Announcements
Insmed’s Brensocatib NDA Accepted by FDA
15d ago
8K
INSM
Insmed: FDA accepts NDA for brensocatib
Premium
The Fly
Insmed: FDA accepts NDA for brensocatib
15d ago
INSM
Joseph Schwartz’s Buy Rating on Insmed Driven by Promising TPIP Developments in Pulmonary Hypertension Treatment
PremiumRatings
Joseph Schwartz’s Buy Rating on Insmed Driven by Promising TPIP Developments in Pulmonary Hypertension Treatment
18d ago
INSM
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
29d ago
ANTX
INSM
Insmed Projects Revenue Growth and Advances Drug Pipeline
PremiumCompany Announcements
Insmed Projects Revenue Growth and Advances Drug Pipeline
1M ago
8K
INSM
Insmed price target raised to $83 from $74 at JPMorgan
PremiumThe Fly
Insmed price target raised to $83 from $74 at JPMorgan
3M ago
INSM
Insmed’s Q3 2024: Strong Growth and Strategic Advances
PremiumCompany AnnouncementsInsmed’s Q3 2024: Strong Growth and Strategic Advances
4M ago
INSM
Insmed reports Q3 EPS ($1.27), consensus ($1.22)
Premium
The Fly
Insmed reports Q3 EPS ($1.27), consensus ($1.22)
4M ago
INSM
INSM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
INSM Earnings this Week: How Will it Perform?
4M ago
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >